Overview

Therapeutic Efficacy and Safety of Palonosetron in Treatment of Postoperative Nausea and Vomiting

Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
This study was designed to evaluate the treatment efficacy and safety of palonosetron for the patients who undergo laparoscopic gynecologic, abdominal or other surgery under general anesthesia.
Phase:
Phase 3
Details
Lead Sponsor:
Samsung Medical Center
Collaborators:
CJ HealthCare Corporation
HK inno.N Corporation
Treatments:
Palonosetron